Connect with us

Industry News

Bhang Commences Trading on the CSE Under the Symbol ‘BHNG’

Avatar

Published

on

default_cannabis_industry_cannamaps

MIAMI, July 11, 2019 (GLOBE NEWSWIRE) — Bhang Corporation (“Bhang” or the “Company”) (CSE: BHNG), a cannabis house of brands with an extensive, award-winning portfolio of products, announced today that, further to its news release on July 9, 2019, it will begin trading on the Canadian Securities Exchange (“CSE”) as Bhang Inc. under the stock symbol “BHNG” on July 11, 2019.
    
“We’re proud to announce this major milestone for Bhang and the industry, as we see a national cannabis brand begin trading on the CSE. This public listing fuels our strategy to meet the growing demand for today’s most innovative cannabis products,” Scott Van Rixel, CEO of Bhang, said. “While our model is not reliant upon accessing the capital markets, our going public transaction will allow us to evaluate new opportunities to accelerate our growth, build our industry-leading house of brands and increase shareholder value.” 
     
Bhang Expanding as a Leading “House of Brands”
Founded in 2010, Bhang has continued to build on its award-winning edibles product line and today has an expansive portfolio of over 100 cannabis, hemp-derived cannabidiol (CBD) and terpene products (which are sold through its licensees and/or by Bhang directly).  International distribution and expansion to more geographies is anticipated in 2019.  Bhang also has a robust pipeline of new products ready to be launched in the next 12 months as it builds a powerful “House of Brands.”
     
Bhang Corporation Highlights:
Bhang is one of the first and most recognized, diversified and established brands in cannabis having won over 30 awards including one of the most awarded cannabis chocolate bars in the world. The existing Bhang brand will serve as the foundation for the Company’s “House of Brands” vertical expansion program, which includes a full suite of THC, hemp-derived CBD, and terpene products, and a CBD brokerage. All of this is driven by Bhang’s product quality, leadership, innovation and longevity which will continue to drive trust in the marketplace.Bhang’s expansive product portfolio combined with its well-established distribution and licensing network position Bhang to capture significant market share across multiple target demographics. Some of the large target markets currently addressed with the Company’s eight active brands and 100-plus products include: the cannabis and hemp-derived CBD market, the performance-athletics market, and the nicotine-cessation market. The Company will be launching eight more brands with new products over the coming months that will address several larger and underserved end-markets as well.Bhang’s soon-to-be introduced terpene products will enable Bhang to gain valuable, retail shelf space and leverage the sales pipeline for other products when regulations permit.Bhang has top-tier manufacturing/distribution partnerships with Trulieve in Florida, Origin House/Cresco in California, and a 50/50 joint-venture with Indiva for Canadian and select worldwide distribution. Vertically-integrated operators’ decisions to partner with Bhang is yet another indication of the strength of the Bhang brand and the quality of the products.  In total, there are currently over 1,000 stores selling Bhang’s brands and this number is expected to exceed 2,000 by the end of the year.   Bhang’s unique low CAPEX/OPEX business model provides multiple revenue stream opportunities including license revenues, wholesale revenues, direct to consumer revenues through bhangcbd.com, and revenues from its CBD brokerage business.Bhang leverages its long-term cannabis industry relationships via its CBD brokerage business, helps satisfy some of the tremendous demand for CBD that currently exists and, in the process, reduces its input costs via the large volume purchase discounts it receives.Bhang is opportunistically evaluating M&A growth opportunities and joint ventures with top manufacturers and leaders in their respective consumer segments.Bhang has carefully assembled a management team that can carry out the Company’s strategy.  The team possesses a combination of experience in the CPG/alcohol/retail sector as well as deep cannabis expertise, making the senior team uniquely positioned to execute on this growing opportunity.   Bhang Senior Management TeamScott J. Van Rixel, Founder, Chairman & Chief Executive Officer.
Cannabis Trailblazer. Brand Architect.
High Times Top 100 in cannabis recipient.  Mr. Rixel has a proven track record in innovative product and brand design from over two decades with major retailers. He is a founding member of the National Cannabis Industry Association and a European certified Chef de Cuisine and Master Chocolatier.
Tom Stein, President  
Mr. Stein is an experienced adult beverage industry leader and executive with focus in execution, distribution, finance, marketing, and M&A. He is a seasoned entrepreneur with a successful management and operational track record. Prior to Bhang, he served in the role of Vice President at Edrington (brands including The Macallan, Highland Park, The Glenrothes, and The Famous Grouse), Director of Sales at Palm Bay and Distributor Manager at Diageo.
Jamie Pearson, Chief Operating Officer and Corporate Secretary
Ms. Pearson is a rare second-generation cannabis executive with decades of experience in global operations, deal structuring and negotiation as a former real estate executive. She was voted one of the High Times most influential women in cannabis. She is fluent in German and English, responsible for European RTM & global operational roll-out across market sectors.
Samantha Collins, Chief Marketing Officer
Ms. Collins is an award-winning brand marketer who held leadership positions at Diageo and Treasury Wine Estates. She has a proven track record of success growing global brands across multiple demographics and geographies.  She is responsible for Bhang’s global brand strategy, brand positioning, innovation and expansion.
   
Jeremy Applen, Chief Science and Procedures Officer
Mr. Applen is a quality management and cannabis system implementation design expert. He served on advisory panels to Association of Public Health Laboratories and Centers for Disease Control and Prevention. Mr. Applen is the Vice Chairman ASTM Committee D37 on cannabis.
Stephen Gledhill, Chief Financial Officer
Mr. Gledhill has over 25 years of financial-control experience and acts as CFO and Corporate Secretary for multiple publicly-traded companies, several of which he was instrumental in scaling up and taking public. Mr. Gledhill has served as the Senior Vice President and CFO of Borealis Capital Corporation, a Toronto-based merchant bank as well as Vice President of Finance of OMERS Realty Corporation (ORC), the real estate entity of the Ontario Municipal Employees Retirement System.
About Bhang
Bhang is committed to delivering exceptional sensory experiences to consumers at every point in their cannabis journey through its award-winning portfolio of brands. Bhang is a trusted cannabis house of brands with an extensive portfolio of over 100 cannabis, hemp-derived CBD and terpene products, including chocolates, pre-rolls, vapes, gums, beverages, gummies and mouth sprays, among others, that are sold by its licensees and/or by Bhang directly. Since 2010, Bhang has mastered the art of harnessing mutually-beneficial partnerships to bring safe, consistent and delicious products to consumers. Learn more at bhangnation.com     
INVESTOR CONTACT:
Valter Pinto / David Hanover
KCSA Strategic Communications
212-896-1254 / 1220
Valter@kcsa.com / DHanover@kcsa.com 
     
MEDIA CONTACT:
Tim Gray/Nick Opich
KCSA Strategic Communications
212-896-1251 / 1206
TGray@kcsa.com / NOpich@kcsa.com 
FORWARD LOOKING STATEMENTS AND DISCLAIMERS
Certain statements contained in this news release may constitute forward-looking information. Forward-looking information is often, but not always, identified by the use of words such as “anticipate”, “plan”, “estimate”, “expect”, “may”, “will”, “intend”, “should”, and similar expressions. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The Company’s actual results could differ materially from those anticipated in this forward-looking information as a result of regulatory decisions, competitive factors in the industries in which the Company operates, prevailing economic conditions, and other factors, many of which are beyond the control of the Company. The Company believes that the expectations reflected in the forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward-looking information contained in this news release represents the Company’s expectations as of the date hereof, and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Original story can be found at: http://www.globenewswire.com/news-release/2019/07/11/1881423/0/en/Bhang-Commences-Trading-on-the-CSE-Under-the-Symbol-BHNG.html?f=22&fvtc=5&fvtv=41223728

Continue Reading

Industry News

CV Sciences, Inc. Expands Operations with New Production and Warehousing Facility to Support Worldwide Growth Opportunities

Avatar

Published

on

default_cannabis_industry_cannamaps

Facility Expansion Increases Hemp CBD Oil Production and Warehousing/Fulfillment Capacity by More Than 500 Percent
SAN DIEGO, July 16, 2019 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products through its industry-dominating brand, PlusCBD™ Oil, today announced the expansion of its operations with a new production and warehouse facility.The 45,500 square foot facility will expand the Company’s capacity for hemp CBD oil production, warehousing and fulfillment by more than 500 percent to meet growing retailer and consumer demand for PlusCBD™ Oil products.  The facility, located in San Diego, is expected to be operational in the fourth quarter of 2019 and will support CV Sciences’ U.S. and international expansion opportunities.“Our recently announced U.S. hemp sourcing initiative combined with this facility and capacity expansion positions CV Sciences for continued rapid domestic growth, while ensuring we are well-positioned to capitalize on the international opportunities we are currently exploring,” said Joseph Dowling, Chief Executive Officer.  “The distribution of PlusCBD™ Oil products into national retailers in the Food, Drug and Mass (FDM) channel is growing significantly, yet we are still in the early stages of growth. Despite more than doubling the number of stores carrying our industry leading products to 4,591 stores in the first six months of this year, we see a significant runway for additional growth, including increasing our domestic and international store count, as well as broadening product SKUs with our retail partners.”On July 10, 2019, CV Sciences announced the commencement of its domestic hemp sourcing initiative, including a commitment to more than 500 acres of U.S.-based hemp production for 2019.  This new supply of U.S. produced hemp-based CBD will be extracted through CV Sciences’ domestic supply chain partners and refined at the Company’s San Diego production facilities, broadening the Company’s global supply chain and raw material supply while reducing transportation and logistics costs.Dowling continued, “CV Sciences is the first hemp CBD company to achieve self-affirmed Generally Recognized as Safe (GRAS) status in accordance with stringent U.S. Food and Drug Administration safety guidelines.  Our relentless commitment to regulatory leadership as well as product safety, quality and efficacy through scientific evidence has established confidence and trust with retailers and consumers.  Expanding our GRAS raw material supply capability builds on our strong foundation to make PlusCBD™ Oil products available to more consumers around the globe.”About CV Sciences, Inc.CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a drug development division focused on developing and commercializing novel therapeutics utilizing CBD. The Company’s PlusCBD™ Oil is the top-selling brand of hemp-based CBD on the market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences, Inc. has primary offices and facilities in San Diego, California.  Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.CONTACT INFORMATION:Investor Contact:
ICR
Scott Van Winkle
617-956-6736
scott.vanwinkle@icrinc.com
Media Contact:
ICR
Cory Ziskind
646-277-1232
cory.ziskind@icrinc.com

Original story can be found at: http://www.globenewswire.com/news-release/2019/07/16/1883333/0/en/CV-Sciences-Inc-Expands-Operations-with-New-Production-and-Warehousing-Facility-to-Support-Worldwide-Growth-Opportunities.html?f=22&fvtc=5&fvtv=41223728

Continue Reading

Industry News

MustGrow Biologics Corp. Featured in Exclusive NetworkNewsWire Broadcast

Avatar

Published

on

default_cannabis_industry_cannamaps

NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) — via NetworkNewsAudio – MustGrow Biologics Corp. (CSE: MGRO), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and bio-fertilizers, today announces the broadcast of its exclusive audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community.
The interview can be heard at http://nnw.fm/WDud1.MustGrow president and CEO Corey Giasson joins NNW host Stuart Smith in a discussion about the company’s novel, proprietary technology that utilizes organic components refined from the mustard seed to provide high-quality organic solutions for growers facing soil borne diseases and pests such as nematodes in their greenhouses and fields.“We’re an agriculture biologics company that has an innovative technology which uses the mustard seed,” Giasson explains. “We take the mustard seed and extract the natural compounds from that mustard seed, concentrate them, and with them they can be used as a natural bio-fumigate or biopesticide in the food and vegetable industry as well as potentially in the cannabis industry.”Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients.MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The company’s initial product was produced in granular form and sold to growers in the fruit and vegetable space, specifically to strawberry growers, Giasson says.“Our second-generation technology is in liquid form and is more concentrated,” he adds. “We are looking forward to getting the regulatory approval to start selling that into the market.”MustGrow’s potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Giasson notes that “a lot of the funguses that affect the strawberry plant also affect the cannabis plant.”The company’s management team and advisory board is stacked with experts in the agriculture biotech industry and vertical biologics, along with renowned experts in the cannabis space such as Tom Flow, founder of The Flowr Corporation. MustGrow recently announced closing of a non-brokered $1.2 million private placement with those funds already dedicated to developing and commercializing its patented technology, finalizing formulations and conducting field tests on cannabis crops.MustGrow’s biopesticide has U.S. EPA (Environmental Protection Agency) and Canadian PMRA (Pest Management Regulatory Agency) labels as an approved organic solution and is seeking approval to add cannabis as an accepted use.About MustGrowMustGrow is an agricultural biotech company focused on developing and commercializing a portfolio of patented natural bio-pesticides and bio-fertilizers, including its patented signature mustard-derived biologics. Targeting the fruit and vegetable and the cannabis industries, MustGrow has designed a U.S. EPA and Canadian PMRA approved organic solution that uses the mustard seed’s natural defense mechanisms to protect plants from pests and diseases.To learn more, please contact the Company at 1 (306) 717-1128 or visit: www.mustgrow.caAbout NetworkNewsAudioNetworkNewsAudio (NNA) , a NetworkNewsWire (NNW) Solution, allows you to sit back and listen to market updates, CEO interviews and a Company AudioPressRelease (APR). These audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio (NNA) can assist your company by cutting through the overload of information in today’s market, NNA brings its clients unparalleled visibility, recognition and brand awareness. NetworkNewsWire (NNW) is where news, content and information converge. NetworkNewsWire (NNW) is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public with an ever-growing distribution network of more than 5,000 key syndication outlets across the nation.For more information, visit: www.NetworkNewsAudio.comPlease see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer.Forward-Looking StatementsThis release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.Corporate Communications:NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com 
212.418.1217 Office 
Editor@NetworkWire.com 

Original story can be found at: http://www.globenewswire.com/news-release/2019/07/16/1883316/0/en/MustGrow-Biologics-Corp-Featured-in-Exclusive-NetworkNewsWire-Broadcast.html?f=22&fvtc=5&fvtv=41223728

Continue Reading

Industry News

Greenlane Granted Second Patent for Pollen Gear™ Child-Resistant SnapTech® Bags

Avatar

Published

on

default_cannabis_industry_cannamaps

BOCA RATON, Fla., July 16, 2019 (GLOBE NEWSWIRE) — Greenlane Holdings, Inc. (Nasdaq: GNLN) (“Greenlane”), a leading distributor of premium vaporization products and consumption accessories, today announced that the U.S. Patent Office has granted the Company its second patent for Pollen Gear’s child-resistant SnapTech® Bags used by leading cannabis brands such as MedMen, Organigram and Farma.
Pollen Gear™, the leading producer of premium, customizable and patented child-resistant packaging solutions, is a wholly-owned subsidiary of Greenlane following its January 2019 acquisition.  Prior to the acquisition, Greenlane was the exclusive global distributor of Pollen Gear products and the companies have a proven track record of bringing industry leading products that promote product safety and responsible consumption to legal cannabis markets.United States Patent Numbers D843,225 and D807,197 cover Pollen Gear’s snap-locking mechanism, which provides cannabis brands with ASTM child-resistant solutions to the ever changing packaging compliance landscape.  This new patent adds to Greenlane’s existing global portfolio of more than 100 patents and patent applications directed across all Pollen Gear container technology, which includes over 30 patents and patent applications for the trendsetting Hi-Line™ jar, a now iconic design that is virtually synonymous with premium cannabis.“The integration of Pollen Gear’s award-winning team of designers and engineers into our business has accelerated our product development and innovation, allowing Greenlane to bring our customers a higher quality of service and a wider array of packaging solutions,” said Aaron LoCascio, Chairman and Chief Executive Officer of Greenlane.  “With this new patent for Pollen Gear’s SnapTech Bags, our customers can be assured that they are using packaging that has been tested at 100% child-resistant effectiveness, ensuring product safety and responsible consumption, while preserving the quality of their cannabis products and brands. We look forward to providing further updates on our packaging innovations as we bring more solutions to market and capitalize on this growth opportunity.”Pollen Gear is a leading supplier of premium child-resistant packaging to the cannabis industry and is credited with creating the category. Founded in 2015, Pollen Gear creates unique packaging solutions, with a focus on recyclable and sustainable materials. Pollen Gear was recognized as a Top 100 Cannabis Company in 2018 by Entrepreneur Magazine.About Greenlane Holdings, Inc.Greenlane (NASDAQ: GNLN) is a leading distributor of premium vaporization products and consumption accessories in the United States and has a growing presence in Canada. Greenlane’s customers include over 7,000 independent smoke shops and regional retail chain stores, which collectively operate approximately 11,000 retail locations, and hundreds of licensed cannabis cultivators, processors and dispensaries. Greenlane also owns and operates one of the most visited North American direct-to-consumer e-commerce websites in the vaporization products and consumption accessories industry, Vapor.com, a unique e-commerce platform which offers convenient, flexible shopping solutions directly to consumers. Through Greenlane’s expansive North American distribution network and e-commerce presence, Greenlane offers a comprehensive selection of premium vaporizers and parts, cleaning products, grinders and storage containers, pipes, rolling papers and customized lines of premium specialty packaging. Following the passage of The Agriculture Improvement Act of 2018 (“The Farm Bill”) in February 2019, Greenlane commenced distribution of premium products containing hemp-derived cannabidiol in those states in which the distribution and sale of such products are authorized by, and can be affected in compliance with, applicable state laws and regulations.Media Contact:
Cory Ziskind
ICR
646-277-1232
greenlane@icrinc.com
Investor Contact:
Scott Van Winkle
ICR
617-956-6736
scott.vanwinkle@icrinc.com

Original story can be found at: http://www.globenewswire.com/news-release/2019/07/16/1883274/0/en/Greenlane-Granted-Second-Patent-for-Pollen-Gear-Child-Resistant-SnapTech-Bags.html?f=22&fvtc=5&fvtv=41223728

Continue Reading

Trending